1. Academic Validation
  2. Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/p53 pathway

Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/p53 pathway

  • Autophagy. 2022 Aug;18(8):1932-1954. doi: 10.1080/15548627.2021.2008752.
Yanhong Xing 1 Xiangqing Wei 2 Yucheng Liu 1 Meng-Meng Wang 3 Zhongheng Sui 1 Xinyan Wang 1 Wucheng Zhu 1 Mengmei Wu 1 Chen Lu 1 Yuan-Hui Fei 1 Yi Jiang 1 Yang Zhang 1 Yuqing Wang 4 Feng Guo 5 Jun-Li Cao 1 Jiansong Qi 1 6 Wuyang Wang 1
Affiliations

Affiliations

  • 1 Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, 209 Tongshan Rd, Xuzhou, Jiangsu 221004, China.
  • 2 Department of Anesthesiology, the Second Affiliated Hospital of Nantong University, Nantong, Jiangsu 226006, China.
  • 3 Department of Otolaryngology and Neck Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110122, China.
  • 4 Department of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University, Fukuoka, 8128582, Japan.
  • 5 Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, China.
  • 6 Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
Abstract

Compelling evidence has demonstrated that macroautophagy/Autophagy plays an important role in regulating multiple steps of metastatic cascades; however, the precise role of Autophagy in metastasis remains unclear. This study demonstrates that Autophagy inhibition induced by MCOLN1/TRPML1 suppresses Cancer metastasis by evoking the ROS-mediated TP53/p53 pathway. First, we found that MCOLN1-mediated Autophagy inhibition not only profoundly inhibits both migration and invasion in malignant melanoma and glioma cell lines in vitro, but also suppresses melanoma metastasis in vivo. Second, our study reveals that Autophagy inhibition induced by MCOLN1 leads to damaged mitochondria accumulation followed by large quantities of ROS release. Third, we demonstrate that the elevated ROS resulting from Autophagy inhibition subsequently triggers TP53 activity, which in turn modulates expression of its downstream targets that are involved in a broad spectrum of the metastatic cascade to suppress metastasis including MMP members and TWIST. In summary, our findings have established a mechanism by which Autophagy inhibition suppresses metastasis via the ROS-TP53 signaling pathway. More importantly, our study demonstrates that Autophagy inhibition through stimulation of MCOLN1 could evidently be one of the therapeutic potentials for combating Cancer metastasis.Abbreviations: 3-MA: 3-methyladenine; AA: amino acid; ATG5: Autophagy related 5; ATG12: autophagy-related 12; Baf-A1: bafilomycin A1; CCCP: carbonyl cyanide m-chlorophenylhydrazone; CQ: chloroquine; DMEM: Dulbecco's Modified Eagle Medium; EMT: epithelial-mesenchymal transition; FBS: fetal bovine serum; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HEK: human embryonic kidney; LAMP1: lysosomal-associated membrane protein 1; MAP1LC3/LC3: microtubule-associated protein 1 LIGHT chain 3; MCOLN1/TRPML1: mucolipin TRP cation channel 1; MMP: matrix metallopeptidase; NC: negative control; NRK: normal rat kidney; PBS: phosphate-buffered saline; shRNA: short hairpin RNA; siRNA: short interfering RNA; SQSTM1/p62: sequestosome 1; ULK1: unc-51 like autophagy-activating kinase 1.

Keywords

Autophagic arrest; MCOLN1; ROS; TP53; metastasis; mitochondria turnover.

Figures
Products